98 related articles for article (PubMed ID: 1672381)
41. Effects of cholinesterase inhibitors and serotonin-1A receptor agonists on morphine-induced ventilatory depression and antinociception in rats.
Kimura S; Ohi Y; Haji A
Eur J Pharmacol; 2013 Mar; 703(1-3):33-41. PubMed ID: 23438874
[TBL] [Abstract][Full Text] [Related]
42. Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity.
Li JX; Shah AP; Patel SK; Rice KC; France CP
Psychopharmacology (Berl); 2013 Feb; 225(4):791-801. PubMed ID: 22993050
[TBL] [Abstract][Full Text] [Related]
43. Contrasting influences of 5-hydroxytryptamine receptors in nitrous oxide antinociception in mice.
Mueller JL; Quock RM
Pharmacol Biochem Behav; 1992 Feb; 41(2):429-32. PubMed ID: 1533464
[TBL] [Abstract][Full Text] [Related]
44. Effects of vietnamese ginseng on opioid agonist - and conditioned fear stress-induced antinociception.
Huong NT; Matsumoto K; Yamasaki K; Duc NM; Nham NT; Watanabe H
Phytomedicine; 1996 May; 3(1):33-9. PubMed ID: 23194858
[TBL] [Abstract][Full Text] [Related]
45. Serotonin receptor antagonists induce hyperalgesia without preventing morphine antinociception.
Berge OG; Fasmer OB; Hole K
Pharmacol Biochem Behav; 1983 Nov; 19(5):873-8. PubMed ID: 6647521
[TBL] [Abstract][Full Text] [Related]
46. Differential sensitivity of models of antinociception in the rat, mouse and guinea-pig to mu- and kappa-opioid receptor agonists.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1987 Aug; 91(4):823-32. PubMed ID: 2822190
[TBL] [Abstract][Full Text] [Related]
47. Morphine analgesia in mice of different ages.
Webster GW; Shuster L; Eleftheriou BE
Exp Aging Res; 1976 May; 2(3):221-33. PubMed ID: 190016
[TBL] [Abstract][Full Text] [Related]
48. Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain.
Haleem DJ
Pharmacol Res; 2018 Aug; 134():212-219. PubMed ID: 29969666
[TBL] [Abstract][Full Text] [Related]
49. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
Paul D; Mana MJ; Pfaus JG; Pinel JP
Pharmacol Biochem Behav; 1988 Nov; 31(3):641-7. PubMed ID: 3251248
[TBL] [Abstract][Full Text] [Related]
50. Evidence of hyperglycemic hyperalgesia by quinpirole.
Roane DS; Paul D
Pharmacol Biochem Behav; 1992 Jan; 41(1):65-7. PubMed ID: 1347178
[TBL] [Abstract][Full Text] [Related]
51. Restraint stress potentiates analgesia induced by 5'-N-ethylcarboxamidoadenosine: comparison with morphine.
Woolfolk DR; Holtzman SG
Eur J Pharmacol; 1993 Aug; 239(1-3):177-82. PubMed ID: 8223892
[TBL] [Abstract][Full Text] [Related]
52. Buspirone, a 5-HT(1A) receptor agonist, dilates the perfused rat uterine vascular bed through alpha(1)-adrenoceptor blockade.
Adeagbo AS; Kadavil EA; Yousif M; Oriowo MA
Gen Pharmacol; 2000 May; 34(5):357-62. PubMed ID: 11368892
[TBL] [Abstract][Full Text] [Related]
53. Cocaine: evidence for NMDA- and opioid-mediated antinociception in the tail-flick test.
Ushijima I; Horita A
Pharmacol Biochem Behav; 1993 Feb; 44(2):365-70. PubMed ID: 8095342
[TBL] [Abstract][Full Text] [Related]
54. Strain differences in mice antinociception: relationship between alprazolam and opioid receptor subtypes.
Pick CG
Eur Neuropsychopharmacol; 1996 Aug; 6(3):201-5. PubMed ID: 8880080
[TBL] [Abstract][Full Text] [Related]
55. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
Bianchi G; Caccia S; Della Vedova F; Garattini S
Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
[TBL] [Abstract][Full Text] [Related]
56. A classification of opiate receptors that mediate antinociception in animals.
Tyers MB
Br J Pharmacol; 1980 Jul; 69(3):503-12. PubMed ID: 6249436
[TBL] [Abstract][Full Text] [Related]
57. Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission.
McMillen BA; Scott SM; Williams HL; Sanghera MK
Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):454-64. PubMed ID: 2439924
[TBL] [Abstract][Full Text] [Related]
58. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.
Rodgers RJ; Shepherd JK
Psychopharmacology (Berl); 1989; 99(3):374-80. PubMed ID: 2574479
[TBL] [Abstract][Full Text] [Related]
59. Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine.
Przegalinski E; Tatarczynska E; Chojnacka-Wójcik E
J Psychopharmacol; 1989 Jan; 3(3):180-5. PubMed ID: 22282903
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological interaction of opiates with various classes of centrally acting dopaminergic drugs.
Fürst S
Drug Metabol Drug Interact; 1991; 9(2):77-102. PubMed ID: 1686855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
